The largest database of trusted experimental protocols

Recombinant human tg2

Manufactured by R&D Systems
Sourced in United States

Recombinant human TG2 is a protein produced using recombinant DNA technology. It is a transglutaminase enzyme that catalyzes the formation of covalent bonds between protein molecules.

Automatically generated - may contain errors

3 protocols using recombinant human tg2

1

Preparation and Coating of TG2-cross-linked Fibrinogen

Check if the same lab product or an alternative is used in the 5 most similar protocols
TG2-cross-linked fibrinogen was prepared as described previously with minor modifications [12 (link)]. Human fibrinogen 1 (Enzyme Research Labs, South Bend, IN, 2.3 μM) was incubated with recombinant human TG2 (R&D Systems, Minneapolis, MN, 0.3 μM) in buffer containing 5 mM CaCl2, 50 mM Tris-HCl, and 274 mM NaCl at 37 °C for 1 hour. Unmodified fibrinogen was prepared under the same conditions, by incubating in buffer containing 5 mM CaCl2, 50 mM Tris-HCl, and 274 mM NaCl at 37 °C for 1 hour, in the absence of TG2. In some experiments, the transglutaminase inhibitor cystamine (Cayman Chemical, Ann Arbor, MI, 0–2.5 mM) was added to the reaction. Purified mouse fibrinogen (Enzyme Research Labs) was used in select experiments, where indicated.
To coat tissue culture plates, fibrinogen and TG2-cross-linked fibrinogen were diluted to 10 μg/mL in sterile phosphate-buffered saline (PBS) and 1 mL, 0.5 mL, or 0.2 mL of solution was added to the wells of 6, 12, or 24-well tissue culture plates (Greiner Bio-One, Monroe, NC), respectively. Plates were incubated overnight at 4 °C and rinsed 3 times with PBS before plating cells.
+ Open protocol
+ Expand
2

Transglutaminase Assay of ATXN1 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the TG assay of ATXN1[82Q], 1 μg of purified human ATXN1[82Q] was mixed with 250 ng of normal or boiled (95°C for 3 minutes) recombinant human TG2 (R&D Systems, 4376) with or without cystamine (Tocris, 4981, final concentration: 40 mM) or LDN-27219 (Tocris, 4602, final concentration: 2 mM) to inhibit Tg activity in TG assay buffer (25 mM Tris-HCl, 5 mM CaCl2, pH 8) supplemented with protease inhibitor cocktail. For the TG assay of ATXN1 with different polyQ-length, 1 μg of purified human ATXN1[2Q], ATXN1[30Q], or ATXN1[82Q] was mixed with 250 ng of recombinant human TG2 in the TG assay buffer supplemented with protease inhibitor cocktail. Total volume of the reaction mixture was 50 μL, and the final concentration of urea was 300 mM. The reaction mixture was incubated at 30°C for an hour with gentle shaking. For terminating TG reaction, NuPAGE LDS sample buffer (4×) was added into reaction mixture and boiled at 95°C for 15 minutes. For Western blot, samples were cooled at room temperature, loaded onto 3%–8% Tris-acetate gels and steps were performed as described above.
+ Open protocol
+ Expand
3

Quantifying Paxillin-Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The optic grating sensor technique, Enspire Multimode Plate Reader (Perkin Elmer, MA, USA), was used to evaluate in-vitro protein interactions. The readout of this assay measured changes in the index of refraction upon a binding event, indicated by a shift of wavelength of the incident light. Briefly, recombinant human paxillin (Biolegend, CA, USA) at a concentration of 0.15 µg/µL was immobilized on the amine-coupling surface of microplate at pH7.5 and incubated overnight at 4 °C. Next day, the non-binding paxillin was washed off with 30uL of pH7.5 PBS for three times. After adding 15 uL of pH7.5 PBS, the plate was read and and the spectral shift was reset arbitrarily to zero. Fifteen microliters of recombinant human TG-2 (R&D, Minnesota, USA), human beta-3 integrin (R&D MN, USA) or vinculin (Abnova, CA, USA) at concentrations ranging from 0.0067 to 0.1 µg/µL was added to the respective wells of the microplate. This is then followed by incubation of the microplate in the Enspire Multimode Plate Reader at 27 °C for 2 hrs. The microplate was washed three times with PBS and then the spectral shift was measured and recorded. In the scenario where there was no significant interaction of the added protein with immobilised paxillin, 15 µL of a third recombinant protein was added into each well and the assay repeated. The above experiments were also repeated at pH 4.3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!